Search research articles
Contact Us
Filters
Showing results (11-20 of 52) with videos related to
Page
of 6
Sort By:
British Journal of Cancer
|
October 21, 2015
The melanoma-specific graded prognostic assessment does not adequately discriminate prognosis in a modern population with brain metastases from malignant melanoma
Anna Wilkins, Andrew Furness, Richard W Corbett, et al.
Radiology. Imaging Cancer
|
January 24, 2025
Evaluation of Local Tumor Outcomes Following Microwave Ablation of Colorectal Liver Metastases Using CT Imaging: A Comparison of Visual versus Quantitative Methods
Joshua D Shur, Nuria Porta, Leila Kafaei, et al.
British Journal of Cancer
|
January 27, 2017
The predictive and prognostic value of tumour necrosis in muscle invasive bladder cancer patients receiving radiotherapy with or without chemotherapy in the BC2001 trial (CRUK/01/004)
Ananya Choudhury, Catharine M West, Nuria Porta, et al.
Cancers
|
January 14, 2021
Image Contrast, Image Pre-Processing, and T<sub>1</sub> Mapping Affect MRI Radiomic Feature Repeatability in Patients with Colorectal Cancer Liver Metastases
Damien J McHugh, Nuria Porta, Ross A Little, et al.
Endocrine
|
September 25, 2015
A specific nursing educational program in patients with Cushing's syndrome
M Antonia Martínez-Momblán, Carmen Gómez, Alicia Santos, et al.
European Urology
|
December 9, 2020
Outcomes in Patients with Muscle-invasive Bladder Cancer Treated with Neoadjuvant Chemotherapy Followed by (Chemo)radiotherapy in the BC2001 Trial
Syed A Hussain, Nuria Porta, Emma Hall, et al.
Clinical and Translational Radiation Oncology
|
September 30, 2020
PIVOTALboost: A phase III randomised controlled trial of prostate and pelvis versus prostate alone radiotherapy with or without prostate boost (CRUK/16/018)
Isabel Syndikus, Clare Cruickshank, John Staffurth, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
September 14, 2021
ATARI trial: ATR inhibitor in combination with olaparib in gynecological cancers with ARID1A loss or no loss (ENGOT/GYN1/NCRI)
Susana Banerjee, James Stewart, Nuria Porta, et al.
European Radiology
|
August 9, 2024
Measuring repeatability of dynamic contrast-enhanced MRI biomarkers improves evaluation of biological response to radiotherapy in lung cancer
Nivetha Sridharan, Ahmed Salem, Ross A Little, et al.
European Urology
|
December 18, 2019
Patient-reported Quality of Life Outcomes in Patients Treated for Muscle-invasive Bladder Cancer with Radiotherapy ± Chemotherapy in the BC2001 Phase III Randomised Controlled Trial
Robert A Huddart, Emma Hall, Rebecca Lewis, et al.
Page
of 6
Search research articles
Search
Showing results (11-20 of 52) with videos related to
Sort By:
Page
of 6
British Journal of Cancer
|
October 21, 2015
The melanoma-specific graded prognostic assessment does not adequately discriminate prognosis in a modern population with brain metastases from malignant melanoma
Anna Wilkins, Andrew Furness, Richard W Corbett, et al.
Radiology. Imaging Cancer
|
January 24, 2025
Evaluation of Local Tumor Outcomes Following Microwave Ablation of Colorectal Liver Metastases Using CT Imaging: A Comparison of Visual versus Quantitative Methods
Joshua D Shur, Nuria Porta, Leila Kafaei, et al.
British Journal of Cancer
|
January 27, 2017
The predictive and prognostic value of tumour necrosis in muscle invasive bladder cancer patients receiving radiotherapy with or without chemotherapy in the BC2001 trial (CRUK/01/004)
Ananya Choudhury, Catharine M West, Nuria Porta, et al.
Cancers
|
January 14, 2021
Image Contrast, Image Pre-Processing, and T<sub>1</sub> Mapping Affect MRI Radiomic Feature Repeatability in Patients with Colorectal Cancer Liver Metastases
Damien J McHugh, Nuria Porta, Ross A Little, et al.
Endocrine
|
September 25, 2015
A specific nursing educational program in patients with Cushing's syndrome
M Antonia Martínez-Momblán, Carmen Gómez, Alicia Santos, et al.
European Urology
|
December 9, 2020
Outcomes in Patients with Muscle-invasive Bladder Cancer Treated with Neoadjuvant Chemotherapy Followed by (Chemo)radiotherapy in the BC2001 Trial
Syed A Hussain, Nuria Porta, Emma Hall, et al.
Clinical and Translational Radiation Oncology
|
September 30, 2020
PIVOTALboost: A phase III randomised controlled trial of prostate and pelvis versus prostate alone radiotherapy with or without prostate boost (CRUK/16/018)
Isabel Syndikus, Clare Cruickshank, John Staffurth, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
September 14, 2021
ATARI trial: ATR inhibitor in combination with olaparib in gynecological cancers with ARID1A loss or no loss (ENGOT/GYN1/NCRI)
Susana Banerjee, James Stewart, Nuria Porta, et al.
European Radiology
|
August 9, 2024
Measuring repeatability of dynamic contrast-enhanced MRI biomarkers improves evaluation of biological response to radiotherapy in lung cancer
Nivetha Sridharan, Ahmed Salem, Ross A Little, et al.
European Urology
|
December 18, 2019
Patient-reported Quality of Life Outcomes in Patients Treated for Muscle-invasive Bladder Cancer with Radiotherapy ± Chemotherapy in the BC2001 Phase III Randomised Controlled Trial
Robert A Huddart, Emma Hall, Rebecca Lewis, et al.
Page
of 6